{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:56:57Z","timestamp":1791341817149,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T00:00:00Z","timestamp":1489795200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006364","name":"INCa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNRS"},{"name":"UCN"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00259-017-3677-5","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T12:04:32Z","timestamp":1489838672000},"page":"1383-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis"],"prefix":"10.1007","volume":"44","author":[{"given":"Lien","family":"Bekaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanu\u00e8le","family":"Lechapt-Zalcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keven","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bordji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Guillamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"issue":"3","key":"3677_CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0360-3016(94)90432-4","volume":"29","author":"R Rampling","year":"1994","unstructured":"Rampling R, Cruickshank G, Lewis AD, Fitzsimmons SA, Workman P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys. 1994;29(3):427\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3677_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"issue":"24","key":"3677_CR3","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1158\/1078-0432.CCR-04-1081","volume":"10","author":"SM Evans","year":"2004","unstructured":"Evans SM, Judy KD, Dunphy I, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res. 2004;10(24):8177\u201384.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3677_CR4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1593\/tlo.09265","volume":"3","author":"SM Evans","year":"2010","unstructured":"Evans SM, Jenkins KW, Chen HI, et al. The relationship among hypoxia, proliferation, and outcome in patients with de novo glioblastoma: a pilot study. Transl Oncol. 2010;3(3):160\u20139.","journal-title":"Transl Oncol"},{"issue":"10","key":"3677_CR5","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1158\/0008-5472.CAN-08-3884","volume":"69","author":"MD Szeto","year":"2009","unstructured":"Szeto MD, Chakraborty G, Hadley J, et al. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. Cancer Res. 2009;69(10):4502\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"3677_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0360-3016(00)01482-6","volume":"49","author":"JM Brown","year":"2001","unstructured":"Brown JM. Therapeutic targets in radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49(2):319\u201326.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3677_CR7","volume-title":"Radiobiology for the radiologist","author":"EJ Hall","year":"2011","unstructured":"Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 7th ed. Philadelphia: LWW; 2011. 576p.","edition":"7"},{"issue":"5","key":"3677_CR8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cncr.23678","volume":"113","author":"JR Flynn","year":"2008","unstructured":"Flynn JR, Wang L, Gillespie DL, et al. Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer. 2008;113(5):1032\u201342.","journal-title":"Cancer"},{"issue":"9","key":"3677_CR9","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","volume":"14","author":"AM Spence","year":"2008","unstructured":"Spence AM, Muzi M, Swanson KR, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res. 2008;14(9):2623\u201330.","journal-title":"Clin Cancer Res"},{"key":"3677_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00057","author":"A Corroyer-Dulmont","year":"2015","unstructured":"Corroyer-Dulmont A, Chakhoyan A, Collet S, et al. Imaging modalities to assess oxygen status in glioblastoma. Front Med. 2015. doi:\n10.3389\/fmed.2015.00057\n\n.","journal-title":"Front Med"},{"issue":"4","key":"3677_CR11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semnuclmed.2008.02.005","volume":"38","author":"W Chen","year":"2008","unstructured":"Chen W, Silverman DHS. Advances in evaluation of primary brain tumors. Semin Nucl Med. 2008;38(4):240\u201350.","journal-title":"Semin Nucl Med"},{"issue":"7","key":"3677_CR12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s002590000260","volume":"27","author":"JM Derlon","year":"2000","unstructured":"Derlon JM, Chapon F, No\u00ebl MH, et al. Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology. Eur J Nucl Med. 2000;27(7):778\u201387.","journal-title":"Eur J Nucl Med"},{"key":"3677_CR13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.nicl.2015.05.012","volume":"8","author":"S Collet","year":"2015","unstructured":"Collet S, Valable S, Constans JM, et al. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas. Neuroimage Clin. 2015;8:448\u201354.","journal-title":"Neuroimage Clin"},{"key":"3677_CR14","first-page":"2133","volume":"33","author":"PE Valk","year":"1992","unstructured":"Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med. 1992;33:2133\u20137.","journal-title":"J Nucl Med"},{"issue":"3","key":"3677_CR15","first-page":"410","volume":"47","author":"LM Cher","year":"2006","unstructured":"Cher LM, Murone C, Lawrentschuk N, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med. 2006;47(3):410\u20138.","journal-title":"J Nucl Med"},{"issue":"6","key":"3677_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","volume":"37","author":"ST Lee","year":"2007","unstructured":"Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Semin Nucl Med. 2007;37(6):451\u201361.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"3677_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","volume":"22","author":"WJ Koh","year":"1992","unstructured":"Koh WJ, Rasey JS, Evans ML, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys. 1992;22(1):199\u2013212.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3677_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","volume":"36","author":"JS Rasey","year":"1996","unstructured":"Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 1996;36(2):417\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3677_CR19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3171\/jns.2000.93.3.0449","volume":"93","author":"HJ Bernsen","year":"2000","unstructured":"Bernsen HJ, Rijken PF, Peters H, et al. Hypoxia in a human intracerebral glioma model. J Neurosurg. 2000;93(3):449\u201354.","journal-title":"J Neurosurg"},{"issue":"6","key":"3677_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn1408","volume":"5","author":"FR Sharp","year":"2004","unstructured":"Sharp FR, Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci. 2004;5(6):437\u201348.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3677_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia, a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer"},{"issue":"37","key":"3677_CR22","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/sj.onc.1206703","volume":"22","author":"NC Denko","year":"2003","unstructured":"Denko NC, Fontana LA, Hudson KM, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 2003;22(37):5907\u201314.","journal-title":"Oncogene"},{"issue":"3","key":"3677_CR23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2007.05.003","volume":"83","author":"HM Said","year":"2007","unstructured":"Said HM, Hagemann C, Staab A, et al. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol. 2007;83(3):398\u2013405.","journal-title":"Radiother Oncol"},{"key":"3677_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","volume":"31","author":"J Pastorek","year":"2015","unstructured":"Pastorek J, Pastorekova S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. Semin Cancer Biol. 2015;31:52\u201364.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3677_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","volume":"328","author":"E Fagiani","year":"2013","unstructured":"Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328(1):18\u201326.","journal-title":"Cancer Lett"},{"issue":"11","key":"3677_CR26","first-page":"1851","volume":"45","author":"M Bruehlmeier","year":"2004","unstructured":"Bruehlmeier M, Roelcke U, Schubiger PA, Ametamey SM. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. J Nucl Med. 2004;45(11):1851\u20139.","journal-title":"J Nucl Med"},{"issue":"6","key":"3677_CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MNM.0b013e3283529984","volume":"33","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Maeda Y, Kawai N, et al. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. Nucl Med Commun. 2012;33(6):621\u20135.","journal-title":"Nucl Med Commun"},{"issue":"10","key":"3677_CR28","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1007\/s00259-014-2776-9","volume":"41","author":"N Kawai","year":"2014","unstructured":"Kawai N, Lin W, Cao W-D, et al. Correlation between 18F-fluoromisonidazole PET and expression of HIF-1\u03b1 and VEGF in newly diagnosed and recurrent malignant gliomas. Eur J Nucl Med Mol Imaging. 2014;41(10):1870\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"3677_CR29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.apradiso.2007.01.005","volume":"65","author":"CW Chang","year":"2007","unstructured":"Chang CW, Chou TK, Liu RS, et al. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO). Appl Radiat Isot. 2007;65(6):682\u20136.","journal-title":"Appl Radiat Isot"},{"issue":"6","key":"3677_CR30","first-page":"781","volume":"38","author":"S Valable","year":"2011","unstructured":"Valable S, Petit E, Roussel S, et al. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model. Nucl Med Biol. 2011;38(6):781\u201393.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"3677_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2967\/jnumed.108.055467","volume":"50","author":"KR Swanson","year":"2009","unstructured":"Swanson KR, Chakraborty G, Wang CH, et al. Complementary but distinct roles for MRI and 18F-Fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med. 2009;50(1):36\u201344.","journal-title":"J Nucl Med"},{"issue":"16","key":"3677_CR32","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1158\/0008-5472.CAN-10-1350","volume":"70","author":"H Yasui","year":"2010","unstructured":"Yasui H, Matsumoto S, Devasahayam N, et al. Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer Res. 2010;70(16):6427\u201336.","journal-title":"Cancer Res"},{"issue":"20","key":"3677_CR33","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1158\/1078-0432.CCR-15-2529","volume":"22","author":"ER Gerstner","year":"2016","unstructured":"Gerstner ER, Zhang Z, Fink JR, et al. ACRIN 6684: assessment of tumor hypoxia in newly diagnosed glioblastoma using 18F-FMISO PET and MRI. Clin Cancer Res. 2016;22(20):5079\u201386.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3677_CR34","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/neuonc\/nou035","volume":"16","author":"A Vartanian","year":"2014","unstructured":"Vartanian A, Singh SK, Agnihotri S, et al. GBM\u2019s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro-Oncology. 2014;16(9):1167\u201375.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"3677_CR35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.semnuclmed.2014.10.001","volume":"45","author":"C Bell","year":"2015","unstructured":"Bell C, Dowson N, Fay M, et al. Hypoxia imaging in gliomas with 18F-fluoromisonidazole PET: toward clinical translation. Semin Nucl Med. 2015;45(2):136\u201350.","journal-title":"Semin Nucl Med"},{"issue":"5","key":"3677_CR36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00259-011-2037-0","volume":"39","author":"K Hirata","year":"2012","unstructured":"Hirata K, Terasaka S, Shiga T, et al. 18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging. 2012;39(5):760\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3677_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167917","author":"T Toyonaga","year":"2016","unstructured":"Toyonaga T, Yamaguchi S, Hirata K, et al. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor. Eur J Nucl Med Mol Imaging. 2016. doi:\n10.1371\/journal.pone.0167917\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3677-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3677-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3677-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:18:39Z","timestamp":1589739519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3677-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,18]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3677"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3677-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,18]]}}}